Trial Profile
Pharmacokinetics of Single Bolus Dose of NovoSeven in Paediatric and Adult Patients With Haemophilia A or B in a Non-Bleeding State
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Eptacog alfa (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 14 Apr 2015 New trial record